Nicole Perry - 11 Jun 2021 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role: Vice President - Accounting
Signature: /s/ David Watson, attorney-in-fact for Nicole Perry
Issuer symbol: APLS
Transactions as of: 11 Jun 2021
Net transactions value: -$58,355
Form type: 4
Filing time: 15 Jun 2021, 16:04:57 UTC
Previous filing: 02 Jun 2021
Next filing: 02 Jul 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APLS	Common Stock	Options Exercise	$3,200	+1,000	+21%	$3.20^*	5,847	11 Jun 2021	Direct
transaction	APLS	Common Stock	Sale	$61,555	-1,000	-17%	$61.56	4,847	11 Jun 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APLS	Stock Option (Right to Buy)	Options Exercise	$0	-1,000	-2.8%	$0.000000	34,161	11 Jun 2021	Common Stock	1,000	$3.20	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option was granted on June 3, 2015 and has vested as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service.